A Cost-Effectiveness Analysis of Neonatal ECMO Using Existing Evidence
- 1 January 1996
- journal article
- clinical trial
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 12 (1) , 80-92
- https://doi.org/10.1017/s0266462300009417
Abstract
A cost-effectiveness analysis is part of the U.K. ECMO Trial. In preparation for this analysis, existing evidence on the costs and effectiveness of neonatal ECMO was evaluated. ECMO appears to be more costly but may be more or less effective than conventional treatment. No case can be made for introducing ECMO before trial results are available.Keywords
This publication has 13 references indexed in Scilit:
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- ECMO in newborn infants: The Melbourne experienceJournal of Paediatrics and Child Health, 1992
- ECMO in newborn infants: The New South Wales experienceJournal of Paediatrics and Child Health, 1992
- Neurodevelopmental outcome in neonates after extracorporeal membrane oxygenation: Cranial magnetic resonance imaging and ultrasonography correlationJournal of Pediatric Surgery, 1992
- Extracorporeal Membrane Oxygenation in a European Center - Clinical ExperienceEuropean Journal of Pediatric Surgery, 1991
- ECMO and outcome of mechanical ventilation in infants of birthweight over 2 kgThe Lancet, 1990
- Hidden mortality rate associated with extracorporeal membrane oxygenationThe Journal of Pediatrics, 1990
- Preliminary report: Extracorporeal lung support for neonatal acute respiratory failureThe Lancet, 1990
- Costs and benefits of neonatal intensive care.Archives of Disease in Childhood, 1988
- An Economic Analysis of Extracorporeal Membrane OxygenationJournal of Intensive Care Medicine, 1987